Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
May 1212:00 PM EDT
-11:59 PM EDT
Make the most of your break with the most realistic GMAT™ prep. Take up to $700 off select products.
May 1308:30 AM PDT
-09:30 AM PDT
In Episode 4 of our GMAT Ninja CR series, we tackle the most intimidating CR question type: Boldface & "Legalese" questions. If you've ever stared at an answer choice that reads, "The first is a consideration introduced to counter a position that...- May 14
08:30 AM PDT
-09:30 AM PDT
Most GMAT test-takers are intimidated by the hardest GMAT Verbal questions. In this session, Target Test Prep GMAT instructor Erika Tyler-John, a 100th percentile GMAT scorer, will show you how top scorers break down challenging Verbal questions..
30 Nov 2020, 10:16
Kudos
Bookmarks
Substance Abuse Treatments Substance Abuse Expenditures Among Payers Mental Health Disorders and Substance Abuse Categorization
From the mid-1980s through the early-2000s, specialty substance abuse centers, facilities that provide both residential and outpatient treatment services, emerged as dominant players in national substance abuse treatment. During the early to mid-1990s, expensive inpatient and residential treatment, viewed as less cost effective than intensive outpatient treatment models, were targeted as an area for cost-cutting, particularly for private insurance. Concurrently, and throughout this time period, sales of prescription drugs have remained a minor portion of spending for substance abuse treatment. Only a few drugs are available to treat substance disorders. In 2004, acamprosate joined two, other previously FDA approved medications–disulfiram and naltrexone–for the treatment of alcoholism. Buprenorphine for the for the treatment of opiate addiction was approved in 2002. Methadone for treatment of opioid addiction is not available as a retail prescription drug and spending for methadone is included with specialty substance abuse centers.
The substance abuse public payer mix is expected to shift toward programs that are wholly or partially funded by state and local governments. Other state and local spending is expected to continue to increase as a share of substance abuse spending throughout the projection period, rising from a 29 percent share in 1986 and a 40 percent share in 2003 to a projected 42 percent share in 2006 and 45 percent share in 2014 as reflected in the figure below.
Private spending on mental health expenditures in 1986 was greater or expected to be greater than public other state and local such expenditures in any year listed.
A. True
B. False
C.
D.
E.
F.
From the mid-1980s through the early-2000s, specialty substance abuse centers, facilities that provide both residential and outpatient treatment services, emerged as dominant players in national substance abuse treatment. During the early to mid-1990s, expensive inpatient and residential treatment, viewed as less cost effective than intensive outpatient treatment models, were targeted as an area for cost-cutting, particularly for private insurance. Concurrently, and throughout this time period, sales of prescription drugs have remained a minor portion of spending for substance abuse treatment. Only a few drugs are available to treat substance disorders. In 2004, acamprosate joined two, other previously FDA approved medications–disulfiram and naltrexone–for the treatment of alcoholism. Buprenorphine for the for the treatment of opiate addiction was approved in 2002. Methadone for treatment of opioid addiction is not available as a retail prescription drug and spending for methadone is included with specialty substance abuse centers.
The substance abuse public payer mix is expected to shift toward programs that are wholly or partially funded by state and local governments. Other state and local spending is expected to continue to increase as a share of substance abuse spending throughout the projection period, rising from a 29 percent share in 1986 and a 40 percent share in 2003 to a projected 42 percent share in 2006 and 45 percent share in 2014 as reflected in the figure below.
Private spending on mental health expenditures in 1986 was greater or expected to be greater than public other state and local such expenditures in any year listed.
A. True
B. False
C.
D.
E.
F.
30 Nov 2020, 10:16
Kudos
Bookmarks
Official Solution:
Substance Abuse Treatments Substance Abuse Expenditures Among Payers Mental Health Disorders and Substance Abuse Categorization
From the mid-1980s through the early-2000s, specialty substance abuse centers, facilities that provide both residential and outpatient treatment services, emerged as dominant players in national substance abuse treatment. During the early to mid-1990s, expensive inpatient and residential treatment, viewed as less cost effective than intensive outpatient treatment models, were targeted as an area for cost-cutting, particularly for private insurance. Concurrently, and throughout this time period, sales of prescription drugs have remained a minor portion of spending for substance abuse treatment. Only a few drugs are available to treat substance disorders. In 2004, acamprosate joined two, other previously FDA approved medications–disulfiram and naltrexone–for the treatment of alcoholism. Buprenorphine for the for the treatment of opiate addiction was approved in 2002. Methadone for treatment of opioid addiction is not available as a retail prescription drug and spending for methadone is included with specialty substance abuse centers.
The substance abuse public payer mix is expected to shift toward programs that are wholly or partially funded by state and local governments. Other state and local spending is expected to continue to increase as a share of substance abuse spending throughout the projection period, rising from a 29 percent share in 1986 and a 40 percent share in 2003 to a projected 42 percent share in 2006 and 45 percent share in 2014 as reflected in the figure below.
Private spending on mental health expenditures in 1986 was greater or expected to be greater than public other state and local such expenditures in any year listed.
A. True
B. False
C.
D.
E.
F.
To add
Answer: B
Substance Abuse Treatments Substance Abuse Expenditures Among Payers Mental Health Disorders and Substance Abuse Categorization
From the mid-1980s through the early-2000s, specialty substance abuse centers, facilities that provide both residential and outpatient treatment services, emerged as dominant players in national substance abuse treatment. During the early to mid-1990s, expensive inpatient and residential treatment, viewed as less cost effective than intensive outpatient treatment models, were targeted as an area for cost-cutting, particularly for private insurance. Concurrently, and throughout this time period, sales of prescription drugs have remained a minor portion of spending for substance abuse treatment. Only a few drugs are available to treat substance disorders. In 2004, acamprosate joined two, other previously FDA approved medications–disulfiram and naltrexone–for the treatment of alcoholism. Buprenorphine for the for the treatment of opiate addiction was approved in 2002. Methadone for treatment of opioid addiction is not available as a retail prescription drug and spending for methadone is included with specialty substance abuse centers.
The substance abuse public payer mix is expected to shift toward programs that are wholly or partially funded by state and local governments. Other state and local spending is expected to continue to increase as a share of substance abuse spending throughout the projection period, rising from a 29 percent share in 1986 and a 40 percent share in 2003 to a projected 42 percent share in 2006 and 45 percent share in 2014 as reflected in the figure below.
Private spending on mental health expenditures in 1986 was greater or expected to be greater than public other state and local such expenditures in any year listed.
A. True
B. False
C.
D.
E.
F.
To add
Answer: B
